UPDATE: THE COVID-19 DETECTION FOUNDATION (dba VIRUFY) and BARDA ANNOUNCE CONTRACT to RESEARCH & DEVELOP COVID-19 SCREENING THROUGH AI/MACHINE LEARNING

Date:

THE COVID-19 DETECTION FOUNDATION (dba VIRUFY) COVID-19 SCREENING THROUGH ARTIFICIAL INTELLIGENCE / MACHINE LEARNING TECHNOLOGY IS THE NEWEST MEMBER OF BARDA'S DIVISION OF RESEARCH, INNOVATION, AND VENTURES (DRIVe) MEDICAL COUNTERMEASURES PORTFOLIO

The COVID-19 Detection Foundation (dba Virufy), a 501(c)(3) non-profit research organization (https://virufy.org) developing a smartphone app for rapid COVID-19 screening through artificial intelligence (AI) / machine learning (ML) technology, today announced that it has been awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR), within the U.S. Department of Health and Human Services (HHS), a U.S. government agency.

This project aims to research and develop COVID-19 screening through AI / ML Technology. Virufy's patented and patent-pending solution gathers a patient's cough/speech data and then, using AI / ML algorithm, rapidly analyzes that data against known COVID-19 Polymerase chain reaction (PCR)-positive, and Covid-19 PCR-negative cough datasets to indicate potential active COVID-19 infection. PCR testing is universally acknowledged as the gold standard in molecular diagnostics and COVID-19 testing.

This Virufy project aims to empower individuals, clinicians, employers, and governments with early, actionable COVID-19 information, to provide cost-effective, faster results for capturing and predicting health events and a reduction in overburdening scarce healthcare resources so that timely responses and medical interventions can be better deployed.

While Virufy has obtained a contract with BARDA, the limited funds are contractually restricted to contract deliverables and data collection, and we remain a 501(c)(3) entity principally staffed by volunteers and pro bono vendors.

"We are profoundly appreciative of the hundreds of volunteers and dozens of pro-bono firms that have selflessly donated their time, creativity, expertise, and compassion in support of our Mission of public good, and for BARDA's / DRIVe's generous support to fund the advancement of Virufy's Covid-19 screening through AI / ML technology," said Virufy CEO, Amil Khanzada. This project has been funded in part with Federal funds from HHS/ASPR and BARDA, under Contract No. 75A50122C00034.

Additional Information -

This award is one component of BARDA's rapidly expanding DRIVe Medical countermeasures portfolio; visit https://drive.hhs.gov to learn more.

About the COVID-19 Detection Foundation (dba Virufy) -

The COVID-19 Detection Foundation (dba Virufy) is a 501(c)(3) nonprofit research organization developing artificial intelligence (AI) / machine learning (ML) technology offering superior, actionable COVID-19 information, to provide faster results for capturing and predicting health events so that timely responses and medical interventions can be deployed.

About HHS, ASPR, and BARDA: The U.S. Department of Health and Human Services works to enhance and protect the health and well-being of all Americans, providing for effective health and human services and fostering advances in medicine, public health, and social services. Within HHS, ASPR leads the nation's medical and public health preparedness for, response to, and recovery from disasters and public health emergencies. As part of ASPR, BARDA provides a comprehensive, integrated, portfolio approach to the advanced research and development, innovation, acquisition, and manufacturing of medical countermeasures - vaccines, drugs, therapeutics, diagnostic tools, and non-pharmaceutical products for public health emergency threats.

To date, BARDA-supported products have achieved over 60 FDA approvals, licensures or clearances. To learn more about BARDA's COVID-19 Portfolio and BARDA's COVID-19 Response, visit www.medicalcountermeasures.gov.

Contact Information:
Patricia Zylberman
PR Manager
[email protected]
+5511972447743


Original Source: UPDATE: THE COVID-19 DETECTION FOUNDATION (dba VIRUFY) and BARDA ANNOUNCE CONTRACT to RESEARCH & DEVELOP COVID-19 SCREENING THROUGH AI/MACHINE LEARNING

Related articles

FAN EXPO Dallas, North Texas’ Signature Pop Culture Blockbuster Event is Brimming with EXCITING Guests and Events

Tickets are on sale NOW for the celebrity-filled weekend from June 7-9, 2024 DALLAS, May 20, 2024 /PRNewswire/...

Cillian Murphy returns for 28 Years Later in “a surprising way”

28 Days Later star Cillian Murphy is said to be returning for the sequel 28 Years Later –...

Hatchet: The Complete Collection Limited Edition Steelbook includes all 4 films

Dark Sky Films is launching their Dark Sky Selects label with the 5-disc Hatchet: The Complete Collection Limited...

Miami Swim Week 2024 Powered By Art Hearts Fashion

Miami Swim Week 2024 Powered By Art Hearts FashionMiami Swim Week Powered By Art Hearts Fashion 2024 dazzled with a blend of style, trends, and unforgettable moments. Celebrating Memorial Day weekend, Art Hearts Fashion kicked off the festivities with Miami Model Week, featuring model castings, pool parties, networking events, and after-parties. On Saturday, May 25, models gathered at Fabel Miami, followed by an […]